Here’s whether Travere Therapeutics, Inc. Common Stock (TVTX) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+9.83% over 10 days); strong 1-year return of +248.3%; 3-month momentum positive (+85.7%). Currently 1.3% off its 52-week high. Score: +6/7.
TVTX is in a confirmed uptrend, trading above both its 50-day ($41.99) and 200-day ($32.89) moving averages. An RSI of 67.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +248.3% compares to +22.9% for SPY (beat the market by 225.5%).
$10,000 invested 1 year ago→ $34,833 today
vs. S&P 500 (SPY) — same period beat market by 225.5%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($32.89)
✓Above 50-day MA ($41.99)
✓RSI(14) neutral zone (30–70) — currently 67.4
✓Positive return (+248.3%)
✓Within 10% of period high (−1.3%)
Period Range $52.04
$13.88$52.72
RSI (14) 67.4
0 · OversoldOverbought · 100
Key Metrics
Price$52.04
Period Return+248.3%
Period High$52.72
Period Low$13.88
Drawdown−1.3%
MA-50$41.99
MA-200$32.89
RSI (14)67.4
Avg Volume (30d)2.4M
vs. SPYbeat by 225.5%
Return Rank#76 of 1246
Trend Signals
Price is above the 200-day moving average ($32.89)